Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialEugenio Mercuri, A. Nascimento, Juan J. Vílchez et al.|The Lancet Neurology|2024Cited by 128
MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis muscleRoberta Morosetti, Giulio Cossu, Maurilio Sampaolesi et al.|Proceedings of the National Academy of Sciences|2006Cited by 72
O.28Safety and tolerability of suvodirsen (WVE-210201) in patients with Duchenne muscular dystrophy: results from a phase 1 clinical trialKathryn R. Wagner, Michael Panzara, H. Phan et al.|Neuromuscular Disorders|2019Cited by 4